Faculty Dr C Durga Rao

Dr C Durga Rao

Professor

Department of Biological Sciences

Contact Details

durgarao.c@srmap.edu.in

Office Location

Education

B.Sc. (Hons) (Chemistry)
Aligarh Muslim University
M.Sc. (Biochemistry)
Aligarh Muslim University
Ph. D. (Microbiology)
Indian Institute of Science

Experience

  • 1988-1993 - Assistant Professor | Indian Institute of Science
  • 1993-1999 - Associate Professor | Indian Institute of Science
  • 1999-2016 - Professor | Indian Institute of Science
  • 2005-2008 - Chairman |Department of Microbiology & Cell Biology, IISc
  • 2016-2019 - INSA Senior Scientist | Indian Institute of Science
  • 2019 - Professor | SRM University AP, Amaravati.

Research Interest

  • Biology of Rotavirus: Epidemiology, Molecular biology and molecular basis of pathogenesis of Rotavirus: structure and function of rotavirus nonstructural proteins, virus replication, and vaccines
  • Biology of human Enteroviruses: Enteroviruses in acute flaccid paralysis and acute diarrhea’ hand-foot-and mouth disease and mechanism of pathogenesis, diagnostics
  • Post-transcriptional regulation of gene expression: Role of AU-rich Element binding proteins in rotaviral mRNA translation, and cellular RNA splicing and polyadenylation.

Awards

  • 2010,  1982 - M. Sreenivasaya Medal for best thesis in Microbiology and Cell Biology, Indian Institute of Science.
  • 2010, 1989-92- Rockefeller Foundation Biotechnology Career Fellowship.
  • 2010, 1990-99- Recipient of Indo-US Vaccine Action Program grants for Rotavirus research and vaccine development.
  • 2010, 1999-2004- Recipient of Bill and Melinda Gates Foundation grant for rotavirus vaccine, development
  • 2010, 1989 - Technology Transfer Award, NIH, USA.
  • 2010, 1990-93 - Visiting Scientist- Stanford University, USA, 2-3 months each year
  • 2010, 1997-2001 & 2008-09 - Visiting Professor, Mount Sinai Medical School, New York, USA, 3 months duration each year.
  • 2010, 2003 - National Biotechnology Award for Process and Product Development, Department of Biotechnology, Govt. of India.
  • 2010, 2006 - Prof. C. R. Krishnamurti Lecture Award, Society of Biological Chemists (I).
  • 2010, 2010 - Prof. J. V. Bhat Endowment Oration- Manipal University, Manipal.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.

Memberships

  • Fellowship/Membership of Professional bodies/National services
  • Fellow, National Academy of Sciences (NASI).
  • Fellow, Indian National Science Academy (INSA)
  • Fellow, Andhra Pradesh Academy of Sciences, (APAS)
  • Member, Executive Committee of Biological Chemists, India (1990-present).
  • Vice president, Society of Biological Chemists, India, 2006-2008.
  • Member, Society of Biological Chemists (India)
  • Member, Indian Society of Cell Biology
  • Member, Indian Association for Cancer Research
  • Member, Guha Research Conference
  • Member, RNA Society, USA
  • Member, American Society for Microbiology, USA
  • Coordinator, University Grants Commission National Resource Networking Center with Rs. 1000 lakhs budget at IISc from 2009-2016
  • Member, Vaccines and Diagnostics Task Force, DBT, 2005-2007
  • Member, Infectious Disease Biology Task Force, DBT, 2009-2013
  • Member, Innovative Young Biotechnology Award (IYBA) Task Force, DBT, 2008-present.
  • Member, BIRAC & BIPP Technical Committees and Task Force ,DBT, 2010-present
  • Chairman, India-UK Welcome Trust-BIRAC Task Force, 2015
  • Editorial Board member of International Journal: Open Virology Journal
  • Member, SAC, NICED, Kolkata, 2016-present

Publications

  • Genetic diversity and prevalence of group A rotavirus infection in children of Imphal, Manipur, India: A hospital-based surveillance study conducted during December 2015 to March 2019

    Damayanti Yengkhom Devi, Chongtham Shyamsunder Singh, C Durga Rao, Nima D Namsa

    Source Title: Vaccine: X, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The study is hospital-based surveillance of rotavirus diarrhea in children from Imphal, Manipur, India conducted from December 2015 to March 2019. The positivity rate was found to be high ?69.25% (358/517) and proportion of diarrhea cases and rotavirus diarrhea was peak in winter months and mostly in children from 6 to 24 months. G3 (43%) was the most widely circulating genotype in Imphal followed by G1 (16%), G2 (8%), G9 (5%), G8 (3%), G10 (1%), and G4 (1%), while G12 (0.26%) was rarely detected. Among P-types, P[6] (22%) accounted for the highest prevalence followed by P[8] (11%) and P[4] (4%), P[11] (4%), P[10] (3%), P-type mixed infection 3%, while 53% were untypeable. In G/P combinations, we detected 22 different rotavirus strains at varying frequencies. Globally distributed G3P[8] and G1P[8] strains were observed in the study. G3P[6] emerged as the most predominant rotavirus strain followed by G3P[8], G1P[6], G1P[8], and G9P[6]. The common rotavirus strains distributed across the region namely G3P[8], G1P[8], G2P[4], G9P[4], G1P[4], G1P[6], and G9P[6] were also observed. Interestingly, our study has observed a high percentage of unusual strains namely G9P[4], G1P[11], G2P[11], G3P[10], G3P[11], G4P[11], G9P[10], G9P[11],G10P[6], and G10P[8]. Of note, the high frequency of non-typeable rotavirus P-types (56%) are suggestive of point mutations that might have accumulated in the primer-binding region of VP4 gene. The findings of the present study revealed the hospital-based prevalence of rotavirus disease and the circulating genotypes during the pre-vaccination period and highlights the need for continuous surveillance of rotavirus infection post-rotavac vaccine introduction in the state of Manipur, India
  • Detecting Tomato Leaf Curl New Delhi Virus Causing Ridge Gourd Yellow Mosaic Disease, and Other Begomoviruses by Antibody-Based Methods

    Priya Naganur, Kodegandlu Subbanna Shankarappa, Raghavendra K Mesta, Chilakalapudi Durga Rao, Venkataravanappa Venkataravanappa, Midatharahally Narasegowda Maruthi, Lakshminarayana Reddy C Narasimha Reddy

    Source Title: Plants, Quartile: Q1

    View abstract ⏷

    The incidence and severity of begomovirus diseases have been increasing around the world recently, and the ridge gourd [Luffa acutangula (Roxb.) L.] is the latest example of a crop that has become highly susceptible to the outbreak of the tomato leaf curl New Delhi virus (ToLCNDV, genus Begomovirus) in India. Accurate diagnosis of causal agents is important in designing disease management strategies. In this study the coat protein (CP) gene from a ToLCNDV-Rg ridge gourd isolate was used to produce polyclonal antibodies (ToLCNDV-Rg-CP-PAb) in a rabbit. The antibodies successfully detected a 30.5 kDa ToLCNDV-Rg-CP in extracts of symptomatic ridge gourd leaf samples by several assays, such as Western Blotting (WB), Dot Immuno Binding Assay (DIBA), Direct Antigen Coating Enzyme Linked Immuno Sorbent Assay (DAC-ELISA), Immuno Capture Polymerase Chain Reaction (IC-PCR), and Immuno Capture Loop-Mediated Isothermal Amplification (IC-LAMP) assays. However, none of the negative samples tested positive in either of the detection methods. Among all the methods tested, the immunocapture assay, IC-LAMP, was the most sensitive in detecting ToLCNDV-Rg. Furthermore, antibodies generated in this study also detected other commonly occurring begomoviruses in South India, such as tomato leaf curl Palampur virus and squash leaf curl China virus in cucurbits. Together, ToLCNDV-Rg-CP-PAb can be used for detecting at least three species of begomoviruses infecting cucurbits. The obtained antibodies will contribute to monitoring disease outbreaks in multiple crops.
  • Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

    Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Sumandeep Kaur, Aditi Kanojia, Christy Margrat Joy, Raju Rajmani, Pallavi Raj Sharma, Sharumathi Jeyasankar, Priya Rani, Radha Krishan Shandil, Shridhar Narayanan, Chilakalapudi Durga

    Source Title: Cell Reports Medicine, Quartile: Q1

    View abstract ⏷

    The COVID-19 pandemic highlights an urgent need for effective antivirals. Targeting host processes co-opted by viruses is an attractive antiviral strategy with a high resistance barrier. Picolinic acid (PA) is a tryptophan metabolite endogenously produced in mammals. Here, we report the broad-spectrum antiviral activity of PA against enveloped viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), flaviviruses, herpes simplex virus, and parainfluenza virus. Mechanistic studies reveal that PA inhibits enveloped virus entry by compromising viral membrane integrity, inhibiting virus-cellular membrane fusion, and interfering with cellular endocytosis. More importantly, in pre-clinical animal models, PA exhibits promising antiviral efficacy against SARS-CoV-2 and IAV. Overall, our data establish PA as a broad-spectrum antiviral with promising pre-clinical efficacy against pandemic viruses SARS-CoV-2 and IAV.
  • Enteroviruses in gastrointestinal diseases

    Chilakalapudi Durga Rao

    Source Title: Reviews in Medical Virology, Quartile: Q1

    View abstract ⏷

    Gastrointestinal diseases including diarrhoea constitute a major cause of morbidity and mortality in infants and young children especially in developing countries. Worldwide deaths among all ages due to diarrhoea during 2015 were estimated to be about 1.31 million, diarrhoeal deaths in children below 5 years of age being 499 000. Rotavirus accounted for about 200 000 deaths. Although diarrhoeal deaths decreased significantly during the last two decades, they still represent the third largest cause of infantile deaths. Several bacterial, viral, parasitic, fungal and non-infectious diarrhoea causing agents have been identified, but 30% to 40% of diarrhoeal cases remain undiagnosed. Enteroviruses transmit by the faecal-oral route and replicate first in intestinal cells before spreading to the target organ. They have been associated with diarrhoea in a few studies, but their causative role in diarrhoea in humans has not been systematically demonstrated. In view of the recent demonstration that enteroviruses cause diarrhoea in newborn mice pups, thus validating Koch's postulates, the purpose of this review is to emphasise the importance of recognising enteroviruses as major gastrointestinal pathogens associated with acute and persistent diarrhoea and non-diarrhoeal increased frequency of bowel movements in infants, young children and adults. Our studies and several other subsequent studies reported from different countries should stimulate strategies to reduce the burden of infantile gastrointestinal disease, which has hitherto remained unaddressed.
  • Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics

    Pratima Ray, Nima D Namsa, Robin Doley, Alak Kumar Buragohain, Partha Pratim Borah, Arpita Devi, Hemanga Gogoi, Bondita Dehingia, Yengkhom Damayanti Devi, Ch Shyamsunder Singh, Chilakalapudi Durga Rao, George M Varghese, Sachin Kumar

    Source Title: Heliyon, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The functional correlation of B- and T-cells to long-lasting immunity against rotavirus infection in the literature is limited. In this work, a series of computational immuno-informatics approaches were applied and identified 28 linear B-cells, 26 conformational B-cell, 44 T C cell and 40 T H cell binding epitopes for structural and non-structural proteins of rotavirus. Further selection of putative B and T cell epitopes in the multi-epitope vaccine construct was carried out based on immunogenicity, conservancy, allergenicity and the helical content of predicted epitopes. An in-silico vaccine constructs was developed using an N-terminal adjuvant (RGD motif) followed by T C and T H cell epitopes and B-cell epitope with an appropriate linker. Multi-threading models of multi-epitope vaccine construct with B- and T-cell epitopes were generated and molecular dynamics simulation was performed to determine the stability of designed vaccine. Codon optimized multi-epitope vaccine antigens was expressed and affinity purified using the E. coli expression system. Further the T cell epitope presentation assay using the recombinant multi-epitope constructs and the T cell epitope predicted and identified in this study have not been investigated. Multi-epitope vaccine construct encompassing predicted B- and T-cell epitopes may help to generate long-term immune responses against rotavirus. The computational findings reported in this study may provide information in developing epitope-based vaccine and diagnostic assay for rotavirus-led diarrhea in children's.

Patents

Projects

  • Understanding the molecular basis for the extreme differential level of expression of genes from human and animal rotaviruses in gene-transfected cells: Implications for improving the growth of human vaccine strains

    Dr C Durga Rao

    Funding Agency: Govt - DBT, Status: Completed

  • Architecture of Rotavirus

    Dr C Durga Rao

    Funding Agency: Sponsoring Agency - SRM University - AP, Budget Cost (INR) Lakhs: 0.6, Status: On Going

  • Finishing studies on the mechanism underlying the lack of expression of human rotaviral nonstructural protein NSP3 in E. coli

    Dr C Durga Rao

    Funding Agency: Sponsoring Agency - SRM University - AP, Budget Cost (INR) Lakhs: 2, Status: On Going

  • Architecture of Rotavirus

    Dr C Durga Rao

    Funding Agency: Sponsoring Agency - SRM University - AP, Budget Cost (INR) Lakhs: 1, Status: On Going

Scholars

Interests

  • Molecular Biology & Cell Biology
  • Molecular Virology
  • Recombinant DNA technology-Vaccines-Diagnostics

Thought Leaderships

There are no Thought Leaderships associated with this faculty.

Top Achievements

Research Area

No research areas found for this faculty.

Education
B.Sc. (Hons) (Chemistry)
Aligarh Muslim University
M.Sc. (Biochemistry)
Aligarh Muslim University
Ph. D. (Microbiology)
Indian Institute of Science
Experience
  • 1988-1993 - Assistant Professor | Indian Institute of Science
  • 1993-1999 - Associate Professor | Indian Institute of Science
  • 1999-2016 - Professor | Indian Institute of Science
  • 2005-2008 - Chairman |Department of Microbiology & Cell Biology, IISc
  • 2016-2019 - INSA Senior Scientist | Indian Institute of Science
  • 2019 - Professor | SRM University AP, Amaravati.
Research Interests
  • Biology of Rotavirus: Epidemiology, Molecular biology and molecular basis of pathogenesis of Rotavirus: structure and function of rotavirus nonstructural proteins, virus replication, and vaccines
  • Biology of human Enteroviruses: Enteroviruses in acute flaccid paralysis and acute diarrhea’ hand-foot-and mouth disease and mechanism of pathogenesis, diagnostics
  • Post-transcriptional regulation of gene expression: Role of AU-rich Element binding proteins in rotaviral mRNA translation, and cellular RNA splicing and polyadenylation.
Awards & Fellowships
  • 2010,  1982 - M. Sreenivasaya Medal for best thesis in Microbiology and Cell Biology, Indian Institute of Science.
  • 2010, 1989-92- Rockefeller Foundation Biotechnology Career Fellowship.
  • 2010, 1990-99- Recipient of Indo-US Vaccine Action Program grants for Rotavirus research and vaccine development.
  • 2010, 1999-2004- Recipient of Bill and Melinda Gates Foundation grant for rotavirus vaccine, development
  • 2010, 1989 - Technology Transfer Award, NIH, USA.
  • 2010, 1990-93 - Visiting Scientist- Stanford University, USA, 2-3 months each year
  • 2010, 1997-2001 & 2008-09 - Visiting Professor, Mount Sinai Medical School, New York, USA, 3 months duration each year.
  • 2010, 2003 - National Biotechnology Award for Process and Product Development, Department of Biotechnology, Govt. of India.
  • 2010, 2006 - Prof. C. R. Krishnamurti Lecture Award, Society of Biological Chemists (I).
  • 2010, 2010 - Prof. J. V. Bhat Endowment Oration- Manipal University, Manipal.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.
Memberships
  • Fellowship/Membership of Professional bodies/National services
  • Fellow, National Academy of Sciences (NASI).
  • Fellow, Indian National Science Academy (INSA)
  • Fellow, Andhra Pradesh Academy of Sciences, (APAS)
  • Member, Executive Committee of Biological Chemists, India (1990-present).
  • Vice president, Society of Biological Chemists, India, 2006-2008.
  • Member, Society of Biological Chemists (India)
  • Member, Indian Society of Cell Biology
  • Member, Indian Association for Cancer Research
  • Member, Guha Research Conference
  • Member, RNA Society, USA
  • Member, American Society for Microbiology, USA
  • Coordinator, University Grants Commission National Resource Networking Center with Rs. 1000 lakhs budget at IISc from 2009-2016
  • Member, Vaccines and Diagnostics Task Force, DBT, 2005-2007
  • Member, Infectious Disease Biology Task Force, DBT, 2009-2013
  • Member, Innovative Young Biotechnology Award (IYBA) Task Force, DBT, 2008-present.
  • Member, BIRAC & BIPP Technical Committees and Task Force ,DBT, 2010-present
  • Chairman, India-UK Welcome Trust-BIRAC Task Force, 2015
  • Editorial Board member of International Journal: Open Virology Journal
  • Member, SAC, NICED, Kolkata, 2016-present
Publications
  • Genetic diversity and prevalence of group A rotavirus infection in children of Imphal, Manipur, India: A hospital-based surveillance study conducted during December 2015 to March 2019

    Damayanti Yengkhom Devi, Chongtham Shyamsunder Singh, C Durga Rao, Nima D Namsa

    Source Title: Vaccine: X, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The study is hospital-based surveillance of rotavirus diarrhea in children from Imphal, Manipur, India conducted from December 2015 to March 2019. The positivity rate was found to be high ?69.25% (358/517) and proportion of diarrhea cases and rotavirus diarrhea was peak in winter months and mostly in children from 6 to 24 months. G3 (43%) was the most widely circulating genotype in Imphal followed by G1 (16%), G2 (8%), G9 (5%), G8 (3%), G10 (1%), and G4 (1%), while G12 (0.26%) was rarely detected. Among P-types, P[6] (22%) accounted for the highest prevalence followed by P[8] (11%) and P[4] (4%), P[11] (4%), P[10] (3%), P-type mixed infection 3%, while 53% were untypeable. In G/P combinations, we detected 22 different rotavirus strains at varying frequencies. Globally distributed G3P[8] and G1P[8] strains were observed in the study. G3P[6] emerged as the most predominant rotavirus strain followed by G3P[8], G1P[6], G1P[8], and G9P[6]. The common rotavirus strains distributed across the region namely G3P[8], G1P[8], G2P[4], G9P[4], G1P[4], G1P[6], and G9P[6] were also observed. Interestingly, our study has observed a high percentage of unusual strains namely G9P[4], G1P[11], G2P[11], G3P[10], G3P[11], G4P[11], G9P[10], G9P[11],G10P[6], and G10P[8]. Of note, the high frequency of non-typeable rotavirus P-types (56%) are suggestive of point mutations that might have accumulated in the primer-binding region of VP4 gene. The findings of the present study revealed the hospital-based prevalence of rotavirus disease and the circulating genotypes during the pre-vaccination period and highlights the need for continuous surveillance of rotavirus infection post-rotavac vaccine introduction in the state of Manipur, India
  • Detecting Tomato Leaf Curl New Delhi Virus Causing Ridge Gourd Yellow Mosaic Disease, and Other Begomoviruses by Antibody-Based Methods

    Priya Naganur, Kodegandlu Subbanna Shankarappa, Raghavendra K Mesta, Chilakalapudi Durga Rao, Venkataravanappa Venkataravanappa, Midatharahally Narasegowda Maruthi, Lakshminarayana Reddy C Narasimha Reddy

    Source Title: Plants, Quartile: Q1

    View abstract ⏷

    The incidence and severity of begomovirus diseases have been increasing around the world recently, and the ridge gourd [Luffa acutangula (Roxb.) L.] is the latest example of a crop that has become highly susceptible to the outbreak of the tomato leaf curl New Delhi virus (ToLCNDV, genus Begomovirus) in India. Accurate diagnosis of causal agents is important in designing disease management strategies. In this study the coat protein (CP) gene from a ToLCNDV-Rg ridge gourd isolate was used to produce polyclonal antibodies (ToLCNDV-Rg-CP-PAb) in a rabbit. The antibodies successfully detected a 30.5 kDa ToLCNDV-Rg-CP in extracts of symptomatic ridge gourd leaf samples by several assays, such as Western Blotting (WB), Dot Immuno Binding Assay (DIBA), Direct Antigen Coating Enzyme Linked Immuno Sorbent Assay (DAC-ELISA), Immuno Capture Polymerase Chain Reaction (IC-PCR), and Immuno Capture Loop-Mediated Isothermal Amplification (IC-LAMP) assays. However, none of the negative samples tested positive in either of the detection methods. Among all the methods tested, the immunocapture assay, IC-LAMP, was the most sensitive in detecting ToLCNDV-Rg. Furthermore, antibodies generated in this study also detected other commonly occurring begomoviruses in South India, such as tomato leaf curl Palampur virus and squash leaf curl China virus in cucurbits. Together, ToLCNDV-Rg-CP-PAb can be used for detecting at least three species of begomoviruses infecting cucurbits. The obtained antibodies will contribute to monitoring disease outbreaks in multiple crops.
  • Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

    Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Sumandeep Kaur, Aditi Kanojia, Christy Margrat Joy, Raju Rajmani, Pallavi Raj Sharma, Sharumathi Jeyasankar, Priya Rani, Radha Krishan Shandil, Shridhar Narayanan, Chilakalapudi Durga

    Source Title: Cell Reports Medicine, Quartile: Q1

    View abstract ⏷

    The COVID-19 pandemic highlights an urgent need for effective antivirals. Targeting host processes co-opted by viruses is an attractive antiviral strategy with a high resistance barrier. Picolinic acid (PA) is a tryptophan metabolite endogenously produced in mammals. Here, we report the broad-spectrum antiviral activity of PA against enveloped viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), flaviviruses, herpes simplex virus, and parainfluenza virus. Mechanistic studies reveal that PA inhibits enveloped virus entry by compromising viral membrane integrity, inhibiting virus-cellular membrane fusion, and interfering with cellular endocytosis. More importantly, in pre-clinical animal models, PA exhibits promising antiviral efficacy against SARS-CoV-2 and IAV. Overall, our data establish PA as a broad-spectrum antiviral with promising pre-clinical efficacy against pandemic viruses SARS-CoV-2 and IAV.
  • Enteroviruses in gastrointestinal diseases

    Chilakalapudi Durga Rao

    Source Title: Reviews in Medical Virology, Quartile: Q1

    View abstract ⏷

    Gastrointestinal diseases including diarrhoea constitute a major cause of morbidity and mortality in infants and young children especially in developing countries. Worldwide deaths among all ages due to diarrhoea during 2015 were estimated to be about 1.31 million, diarrhoeal deaths in children below 5 years of age being 499 000. Rotavirus accounted for about 200 000 deaths. Although diarrhoeal deaths decreased significantly during the last two decades, they still represent the third largest cause of infantile deaths. Several bacterial, viral, parasitic, fungal and non-infectious diarrhoea causing agents have been identified, but 30% to 40% of diarrhoeal cases remain undiagnosed. Enteroviruses transmit by the faecal-oral route and replicate first in intestinal cells before spreading to the target organ. They have been associated with diarrhoea in a few studies, but their causative role in diarrhoea in humans has not been systematically demonstrated. In view of the recent demonstration that enteroviruses cause diarrhoea in newborn mice pups, thus validating Koch's postulates, the purpose of this review is to emphasise the importance of recognising enteroviruses as major gastrointestinal pathogens associated with acute and persistent diarrhoea and non-diarrhoeal increased frequency of bowel movements in infants, young children and adults. Our studies and several other subsequent studies reported from different countries should stimulate strategies to reduce the burden of infantile gastrointestinal disease, which has hitherto remained unaddressed.
  • Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics

    Pratima Ray, Nima D Namsa, Robin Doley, Alak Kumar Buragohain, Partha Pratim Borah, Arpita Devi, Hemanga Gogoi, Bondita Dehingia, Yengkhom Damayanti Devi, Ch Shyamsunder Singh, Chilakalapudi Durga Rao, George M Varghese, Sachin Kumar

    Source Title: Heliyon, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The functional correlation of B- and T-cells to long-lasting immunity against rotavirus infection in the literature is limited. In this work, a series of computational immuno-informatics approaches were applied and identified 28 linear B-cells, 26 conformational B-cell, 44 T C cell and 40 T H cell binding epitopes for structural and non-structural proteins of rotavirus. Further selection of putative B and T cell epitopes in the multi-epitope vaccine construct was carried out based on immunogenicity, conservancy, allergenicity and the helical content of predicted epitopes. An in-silico vaccine constructs was developed using an N-terminal adjuvant (RGD motif) followed by T C and T H cell epitopes and B-cell epitope with an appropriate linker. Multi-threading models of multi-epitope vaccine construct with B- and T-cell epitopes were generated and molecular dynamics simulation was performed to determine the stability of designed vaccine. Codon optimized multi-epitope vaccine antigens was expressed and affinity purified using the E. coli expression system. Further the T cell epitope presentation assay using the recombinant multi-epitope constructs and the T cell epitope predicted and identified in this study have not been investigated. Multi-epitope vaccine construct encompassing predicted B- and T-cell epitopes may help to generate long-term immune responses against rotavirus. The computational findings reported in this study may provide information in developing epitope-based vaccine and diagnostic assay for rotavirus-led diarrhea in children's.
Contact Details

durgarao.c@srmap.edu.in

Scholars
Interests

  • Molecular Biology & Cell Biology
  • Molecular Virology
  • Recombinant DNA technology-Vaccines-Diagnostics

Education
B.Sc. (Hons) (Chemistry)
Aligarh Muslim University
M.Sc. (Biochemistry)
Aligarh Muslim University
Ph. D. (Microbiology)
Indian Institute of Science
Experience
  • 1988-1993 - Assistant Professor | Indian Institute of Science
  • 1993-1999 - Associate Professor | Indian Institute of Science
  • 1999-2016 - Professor | Indian Institute of Science
  • 2005-2008 - Chairman |Department of Microbiology & Cell Biology, IISc
  • 2016-2019 - INSA Senior Scientist | Indian Institute of Science
  • 2019 - Professor | SRM University AP, Amaravati.
Research Interests
  • Biology of Rotavirus: Epidemiology, Molecular biology and molecular basis of pathogenesis of Rotavirus: structure and function of rotavirus nonstructural proteins, virus replication, and vaccines
  • Biology of human Enteroviruses: Enteroviruses in acute flaccid paralysis and acute diarrhea’ hand-foot-and mouth disease and mechanism of pathogenesis, diagnostics
  • Post-transcriptional regulation of gene expression: Role of AU-rich Element binding proteins in rotaviral mRNA translation, and cellular RNA splicing and polyadenylation.
Awards & Fellowships
  • 2010,  1982 - M. Sreenivasaya Medal for best thesis in Microbiology and Cell Biology, Indian Institute of Science.
  • 2010, 1989-92- Rockefeller Foundation Biotechnology Career Fellowship.
  • 2010, 1990-99- Recipient of Indo-US Vaccine Action Program grants for Rotavirus research and vaccine development.
  • 2010, 1999-2004- Recipient of Bill and Melinda Gates Foundation grant for rotavirus vaccine, development
  • 2010, 1989 - Technology Transfer Award, NIH, USA.
  • 2010, 1990-93 - Visiting Scientist- Stanford University, USA, 2-3 months each year
  • 2010, 1997-2001 & 2008-09 - Visiting Professor, Mount Sinai Medical School, New York, USA, 3 months duration each year.
  • 2010, 2003 - National Biotechnology Award for Process and Product Development, Department of Biotechnology, Govt. of India.
  • 2010, 2006 - Prof. C. R. Krishnamurti Lecture Award, Society of Biological Chemists (I).
  • 2010, 2010 - Prof. J. V. Bhat Endowment Oration- Manipal University, Manipal.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.
  • 2010, 2016 - Courage Fund Invited Speaker: Hand Foot and Mouth disease symposium, Singapore, July 24-26.
Memberships
  • Fellowship/Membership of Professional bodies/National services
  • Fellow, National Academy of Sciences (NASI).
  • Fellow, Indian National Science Academy (INSA)
  • Fellow, Andhra Pradesh Academy of Sciences, (APAS)
  • Member, Executive Committee of Biological Chemists, India (1990-present).
  • Vice president, Society of Biological Chemists, India, 2006-2008.
  • Member, Society of Biological Chemists (India)
  • Member, Indian Society of Cell Biology
  • Member, Indian Association for Cancer Research
  • Member, Guha Research Conference
  • Member, RNA Society, USA
  • Member, American Society for Microbiology, USA
  • Coordinator, University Grants Commission National Resource Networking Center with Rs. 1000 lakhs budget at IISc from 2009-2016
  • Member, Vaccines and Diagnostics Task Force, DBT, 2005-2007
  • Member, Infectious Disease Biology Task Force, DBT, 2009-2013
  • Member, Innovative Young Biotechnology Award (IYBA) Task Force, DBT, 2008-present.
  • Member, BIRAC & BIPP Technical Committees and Task Force ,DBT, 2010-present
  • Chairman, India-UK Welcome Trust-BIRAC Task Force, 2015
  • Editorial Board member of International Journal: Open Virology Journal
  • Member, SAC, NICED, Kolkata, 2016-present
Publications
  • Genetic diversity and prevalence of group A rotavirus infection in children of Imphal, Manipur, India: A hospital-based surveillance study conducted during December 2015 to March 2019

    Damayanti Yengkhom Devi, Chongtham Shyamsunder Singh, C Durga Rao, Nima D Namsa

    Source Title: Vaccine: X, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The study is hospital-based surveillance of rotavirus diarrhea in children from Imphal, Manipur, India conducted from December 2015 to March 2019. The positivity rate was found to be high ?69.25% (358/517) and proportion of diarrhea cases and rotavirus diarrhea was peak in winter months and mostly in children from 6 to 24 months. G3 (43%) was the most widely circulating genotype in Imphal followed by G1 (16%), G2 (8%), G9 (5%), G8 (3%), G10 (1%), and G4 (1%), while G12 (0.26%) was rarely detected. Among P-types, P[6] (22%) accounted for the highest prevalence followed by P[8] (11%) and P[4] (4%), P[11] (4%), P[10] (3%), P-type mixed infection 3%, while 53% were untypeable. In G/P combinations, we detected 22 different rotavirus strains at varying frequencies. Globally distributed G3P[8] and G1P[8] strains were observed in the study. G3P[6] emerged as the most predominant rotavirus strain followed by G3P[8], G1P[6], G1P[8], and G9P[6]. The common rotavirus strains distributed across the region namely G3P[8], G1P[8], G2P[4], G9P[4], G1P[4], G1P[6], and G9P[6] were also observed. Interestingly, our study has observed a high percentage of unusual strains namely G9P[4], G1P[11], G2P[11], G3P[10], G3P[11], G4P[11], G9P[10], G9P[11],G10P[6], and G10P[8]. Of note, the high frequency of non-typeable rotavirus P-types (56%) are suggestive of point mutations that might have accumulated in the primer-binding region of VP4 gene. The findings of the present study revealed the hospital-based prevalence of rotavirus disease and the circulating genotypes during the pre-vaccination period and highlights the need for continuous surveillance of rotavirus infection post-rotavac vaccine introduction in the state of Manipur, India
  • Detecting Tomato Leaf Curl New Delhi Virus Causing Ridge Gourd Yellow Mosaic Disease, and Other Begomoviruses by Antibody-Based Methods

    Priya Naganur, Kodegandlu Subbanna Shankarappa, Raghavendra K Mesta, Chilakalapudi Durga Rao, Venkataravanappa Venkataravanappa, Midatharahally Narasegowda Maruthi, Lakshminarayana Reddy C Narasimha Reddy

    Source Title: Plants, Quartile: Q1

    View abstract ⏷

    The incidence and severity of begomovirus diseases have been increasing around the world recently, and the ridge gourd [Luffa acutangula (Roxb.) L.] is the latest example of a crop that has become highly susceptible to the outbreak of the tomato leaf curl New Delhi virus (ToLCNDV, genus Begomovirus) in India. Accurate diagnosis of causal agents is important in designing disease management strategies. In this study the coat protein (CP) gene from a ToLCNDV-Rg ridge gourd isolate was used to produce polyclonal antibodies (ToLCNDV-Rg-CP-PAb) in a rabbit. The antibodies successfully detected a 30.5 kDa ToLCNDV-Rg-CP in extracts of symptomatic ridge gourd leaf samples by several assays, such as Western Blotting (WB), Dot Immuno Binding Assay (DIBA), Direct Antigen Coating Enzyme Linked Immuno Sorbent Assay (DAC-ELISA), Immuno Capture Polymerase Chain Reaction (IC-PCR), and Immuno Capture Loop-Mediated Isothermal Amplification (IC-LAMP) assays. However, none of the negative samples tested positive in either of the detection methods. Among all the methods tested, the immunocapture assay, IC-LAMP, was the most sensitive in detecting ToLCNDV-Rg. Furthermore, antibodies generated in this study also detected other commonly occurring begomoviruses in South India, such as tomato leaf curl Palampur virus and squash leaf curl China virus in cucurbits. Together, ToLCNDV-Rg-CP-PAb can be used for detecting at least three species of begomoviruses infecting cucurbits. The obtained antibodies will contribute to monitoring disease outbreaks in multiple crops.
  • Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo

    Rohan Narayan, Mansi Sharma, Rajesh Yadav, Abhijith Biji, Sumandeep Kaur, Aditi Kanojia, Christy Margrat Joy, Raju Rajmani, Pallavi Raj Sharma, Sharumathi Jeyasankar, Priya Rani, Radha Krishan Shandil, Shridhar Narayanan, Chilakalapudi Durga

    Source Title: Cell Reports Medicine, Quartile: Q1

    View abstract ⏷

    The COVID-19 pandemic highlights an urgent need for effective antivirals. Targeting host processes co-opted by viruses is an attractive antiviral strategy with a high resistance barrier. Picolinic acid (PA) is a tryptophan metabolite endogenously produced in mammals. Here, we report the broad-spectrum antiviral activity of PA against enveloped viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), flaviviruses, herpes simplex virus, and parainfluenza virus. Mechanistic studies reveal that PA inhibits enveloped virus entry by compromising viral membrane integrity, inhibiting virus-cellular membrane fusion, and interfering with cellular endocytosis. More importantly, in pre-clinical animal models, PA exhibits promising antiviral efficacy against SARS-CoV-2 and IAV. Overall, our data establish PA as a broad-spectrum antiviral with promising pre-clinical efficacy against pandemic viruses SARS-CoV-2 and IAV.
  • Enteroviruses in gastrointestinal diseases

    Chilakalapudi Durga Rao

    Source Title: Reviews in Medical Virology, Quartile: Q1

    View abstract ⏷

    Gastrointestinal diseases including diarrhoea constitute a major cause of morbidity and mortality in infants and young children especially in developing countries. Worldwide deaths among all ages due to diarrhoea during 2015 were estimated to be about 1.31 million, diarrhoeal deaths in children below 5 years of age being 499 000. Rotavirus accounted for about 200 000 deaths. Although diarrhoeal deaths decreased significantly during the last two decades, they still represent the third largest cause of infantile deaths. Several bacterial, viral, parasitic, fungal and non-infectious diarrhoea causing agents have been identified, but 30% to 40% of diarrhoeal cases remain undiagnosed. Enteroviruses transmit by the faecal-oral route and replicate first in intestinal cells before spreading to the target organ. They have been associated with diarrhoea in a few studies, but their causative role in diarrhoea in humans has not been systematically demonstrated. In view of the recent demonstration that enteroviruses cause diarrhoea in newborn mice pups, thus validating Koch's postulates, the purpose of this review is to emphasise the importance of recognising enteroviruses as major gastrointestinal pathogens associated with acute and persistent diarrhoea and non-diarrhoeal increased frequency of bowel movements in infants, young children and adults. Our studies and several other subsequent studies reported from different countries should stimulate strategies to reduce the burden of infantile gastrointestinal disease, which has hitherto remained unaddressed.
  • Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics

    Pratima Ray, Nima D Namsa, Robin Doley, Alak Kumar Buragohain, Partha Pratim Borah, Arpita Devi, Hemanga Gogoi, Bondita Dehingia, Yengkhom Damayanti Devi, Ch Shyamsunder Singh, Chilakalapudi Durga Rao, George M Varghese, Sachin Kumar

    Source Title: Heliyon, Quartile: Q1

    View abstract ⏷

    Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The functional correlation of B- and T-cells to long-lasting immunity against rotavirus infection in the literature is limited. In this work, a series of computational immuno-informatics approaches were applied and identified 28 linear B-cells, 26 conformational B-cell, 44 T C cell and 40 T H cell binding epitopes for structural and non-structural proteins of rotavirus. Further selection of putative B and T cell epitopes in the multi-epitope vaccine construct was carried out based on immunogenicity, conservancy, allergenicity and the helical content of predicted epitopes. An in-silico vaccine constructs was developed using an N-terminal adjuvant (RGD motif) followed by T C and T H cell epitopes and B-cell epitope with an appropriate linker. Multi-threading models of multi-epitope vaccine construct with B- and T-cell epitopes were generated and molecular dynamics simulation was performed to determine the stability of designed vaccine. Codon optimized multi-epitope vaccine antigens was expressed and affinity purified using the E. coli expression system. Further the T cell epitope presentation assay using the recombinant multi-epitope constructs and the T cell epitope predicted and identified in this study have not been investigated. Multi-epitope vaccine construct encompassing predicted B- and T-cell epitopes may help to generate long-term immune responses against rotavirus. The computational findings reported in this study may provide information in developing epitope-based vaccine and diagnostic assay for rotavirus-led diarrhea in children's.
Contact Details

durgarao.c@srmap.edu.in

Scholars